New single-dose oral treatment for human African trypanosomiasis (sleeping sickness)

View source ↗

Summary

EMA approved acoziborole as a single-dose oral treatment for both stages of gambiense human African trypanosomiasis, simplifying management of sleeping sickness…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Acoziborole (acoziborole)

Snippet

Acoziborole Winthrop simplifies treatment of first- and second-stage disease caused by T. brucei gambiense